Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT03205956
Eligibility Criteria:
Inclusion Criteria:
* Age 40-79 at screening
* Meet accepted diagnostic criteria for Parkinson disease
Exclusion Criteria: Key exclusion criteria:
* Deep brain stimulator (DBS)
* Pregnancy
* Patients taking a dopamine antagonist (like quetiapine) or dopamine partial agonist (like aripiprazole)
* Metal in the head or eye, or other contraindication to MRI
* Claustrophobia
* Serious neurologic disease other than PD
* Head trauma with loss of consciousness for more than 5 minutes
* Severe or unstable systemic illness
* Certain psychiatric illnesses (dementia, psychosis, current major depression)
* Current alcohol use disorder
* Subjects who feel that going without nicotine for 3-4 hours would be uncomfortable
* Currently taking an extended-release formulation of a dopamine agonist (like Mirapex ER or Requip XL)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
79 Years
Study:
NCT03205956
Study Brief:
Protocol Section:
NCT03205956